VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung

R. T. Eagan, E. T. Creagan, J. N. Ingle, J. Rubin, S. Frytak, L. K. Kvols, T. R. Fleming

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint Dive into the research topics of 'VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung'. Together they form a unique fingerprint.

Medicine & Life Sciences